Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Oklahoma”
179 pharma patents match "The Board of Regents of the University of Oklahoma" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 179 pharmaceutical patents matching "The Board of Regents of the University of Oklahoma" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10464983
Variants of adrenomedullin and calcitonin gene-related peptide and methods of use
granted -
US 10398668
Glutamate treatment of cardiovascular disorders
granted -
US 10392642
High molecular weight heparosan polymers and methods of production and use thereof
granted -
US 10258613
Compositions for treating retinal degeneration and methods of production and use thereof
granted -
US 10226523
Clostridium difficile vaccine and methods of use
granted -
US 10206904
Licofelone derivatives and methods of use
granted -
US 10174077
Method of inhibiting activity of cell surface fibroblast activation protein alpha
granted -
US 10155789
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
granted -
US 10073109
Phages of biomarker capture and methods of use
granted -
US 9987241
Enzyme conjugate and prodrug cancer therapy
granted -
US 9969803
Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof
granted -
US 9957305
Anti-C. difficile toxin antibodies and associated methods
granted -
US 9950037
Enhancing progenitor cell numbers
granted -
US 9925209
Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
granted -
US 9902690
Ethoxylated surfactants
granted -
US 9885072
High molecular weight heparosan polymers and methods of production of use thereof
granted -
US 9862748
Peptide compounds and methods of production and use thereof
granted -
US 9839690
Singlet oxygen-labile linkers and methods of production and use thereof
granted -
US 9744235
Treatment of cardiovascular disorders with targeted nanoparticles
granted -
US 9688722
Substrates and inhibitors of prolyl oligopeptidase and methods of use
granted -
US 9687559
Heparosan polymers and methods of making and using same for the enhancement of therapeutics
granted -
US 9675662
Compositions for inhibition of RNA polymerase I and methods of production and use thereof
granted -
US 9663585
Anti-DCLK1 monoclonal antibodies and methods of production and use thereof
granted -
US 9629914
Heparosan-based biomaterials and coatings and methods of production and use thereof
granted